Yasemin AKÇA
(Gaziantep Üniversitesi, Tıp Fakültesi Tıbbi Patoloji Anabilim Dalı, Gaziantep, Türkiye)
Murat ALPER
(Tıbbi Patoloji Anabilim Dalı, Dişkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Ankara, Türkiye)
Yıl: 2021Cilt: 4Sayı: 2ISSN: 2618-6454 / 2618-6454Sayfa Aralığı: 72 - 80İngilizce

59 0
The prognostic and predictive value of osteopontin in colon adenocarcinoma
Aim: The identification of cellular pathways in colorectal tumor biology is essential for early diagnosis,treatment, and post-treatment follow-up. Osteopontin is an extracellular matrix protein that has regulatoryphysiological functions and roles in apoptosis, proliferation, adhesion, invasion, and tumor metastasis. In thisstudy, we aimed to determine the prognostic and predictive value of osteopontin in colon adenocarcinoma.Our study investigated whether osteopontin expression had any prognostic or predictive use in colonadenocarcinoma and also if there were any differences between adenocarcinoma and adenoma.Methods: Fifty of these colonic specimens were adenocarcinoma, 16 were adenomatous polyps, and 10 werenontumoral colonic tissue that served as a control group. We used a two-tiered evaluation system that examinedboth the staining intensity and the percentage of staining.Results: The staining scores of tumors with vascular invasion were significantly higher than those of tumorswithout vascular invasion. In addition, the tumoral tissues’ osteopontin staining scores were significantlyhigher than the score of polyps.Conclusion: If future studies support our results, we suggest that osteopontin may be an important biomarkerfor predicting or detecting vascular invasion in tumors and could be useful in tumor-adenomatous polypdifferentiation. Therefore, osteopontin can provide helpful information in the diagnosis and prognosis of colonadenocarcinoma.
DergiAraştırma MakalesiErişime Açık
  • [1]Hamilton SR, Bosman FT, Boffeta P. Colon and rectum. Bosman FT, Carneiro F, Hruban RH, editors. Tumors of the colon and rectum. WHO Classification of tumours of the Digestive System, 4th ed. Lyon: 2010. p.134.
  • [2]Senger DR, Wirth DF, Hynes RO. Transformed mammalian cells secrete specific proteins and phosphoproteins. Cell. 1979; 16(4):885-93.
  • [3]Wai PY, Kuo PC. The role of Osteopontin in tumor metastasis. J Surg Res. 2004; 121(2):228-41.
  • [4] Weber GF, Lett GS, Haubein NC. Osteopontin, is a marker for cancer aggressiveness and patient survival. Br J Cancer. 2010; 103(6):861-69.
  • [5]Weber GF. The cancer biomarker osteopontin: combination with other markers. Cancer Genomics Proteomics. 2011; 8(6):263–88.
  • [6]Wei R, Wong JPC, Kwok HF. Osteopontin, a promising biomarker for cancer therapy. J Cancer. 2017; 8(12)2173-83.
  • [7]Shevde LA, Samant RS. Role of osteopontin in the pathophysiology of cancer. Matrix Biol. 2014; 37:131–41.
  • [8]Allred DC, Bustamante MA, Daniel CO, et al. Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevalence. Arch Surg. 1990; 125(1):107-13.
  • [9]Craig AM, Smith JH, Denhardt DT. Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis. J Biol Chem. 1989; 264(16):9682–89.
  • [10]Mazzali M, Kipari T, Ophascharoensuk V, et al. Osteopontin a molecule for all seasons. QMJ. 2002; 95(1):3-13.
  • [11]Rittling SR, Chambers AF. Role of osteopontin in tumour progression. Br J Cancer. 2004; 90(10):1877-81.
  • [12]Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signalling and cancer progression. Trends Cell Biol. 2006; 16(2):79-87.
  • [13]Hirama M, Takahashi F, Takahashi K, et al. Osteopontin overproduced by tumour cells acts as a potent angiogenic factor contributing to tumour growth. Cancer Lett. 2003; 198(1):107-17.
  • [14]Jessup JM, Goldberg RM, Asare EA. Colon and rectum. Amin MB, Edge SB, Greene FL, editors. AJCC Cancer Staging Manual Eight Edition. Chicago: Springer. 2017. p.251- 274.
  • [15]Wei R, Wong JPC, Lyu P, et al. In Vitro and Clinical Data Analysis of Osteopontin as a Prognostic Indicator in Colorectal Cancer. J Cell Mol Med. 2018. 22(9):4097-105.
  • [16]Korita PV, Wakai T, Shirai Y, et al. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma. Hum Pathol. 2008;39(12):1777-83.
  • [17]Likui W, Hong W, Shuwen Z. Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer. J Gastrointest Surg. 2010;14(1):74- 81.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.